Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | DOP1B (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DOP1B mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Dop1b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DOPEY2 mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | increases expression | ISO | Dop1b (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of DOPEY2 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Dop1b (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of DOPEY2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Estradiol results in decreased expression of DOP1B mRNA | CTD | PMID:19167446 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of DOPEY2 mRNA | CTD | PMID:32145629 | 17beta-estradiol | multiple interactions | ISO | DOP1B (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of DOP1B mRNA | CTD | PMID:30165855 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Dop1b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DOP1B mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of DOP1B mRNA | CTD | PMID:34747641 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of DOP1B mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of DOPEY2 mRNA | CTD | PMID:30851411 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of DOP1B protein | CTD | PMID:31675489 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Dop1b (Mus musculus) | 6480464 | bisphenol S results in decreased expression of DOPEY2 mRNA | CTD | PMID:33297965 | aflatoxin B1 | affects methylation | ISO | DOP1B (Homo sapiens) | 6480464 | Aflatoxin B1 affects the methylation of DOP1B intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | affects methylation | ISO | DOP1B (Homo sapiens) | 6480464 | aflatoxin B2 affects the methylation of DOP1B intron | CTD | PMID:30157460 | Aroclor 1254 | decreases expression | ISO | Dop1b (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of DOP1B mRNA | CTD | PMID:23650126 | arsenite(3-) | decreases methylation | ISO | DOP1B (Homo sapiens) | 6480464 | arsenite results in decreased methylation of DOP1B promoter | CTD | PMID:23974009 | arsenite(3-) | multiple interactions | ISO | DOP1B (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to DOP1B mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases mutagenesis | ISO | DOP1B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of DOP1B gene | CTD | PMID:25435355 | benzo[a]pyrene | decreases expression | ISO | Dop1b (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of DOP1B mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases methylation | ISO | DOP1B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of DOPEY2 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of DOP1B mRNA | CTD | PMID:20064835 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 | benzo[e]pyrene | decreases methylation | ISO | DOP1B (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of DOP1B intron | CTD | PMID:30157460 | bis(2-ethylhexyl) phthalate | increases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of DOPEY2 mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of DOP1B mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of DOP1B protein | CTD | PMID:31675489 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of DOP1B mRNA and bisphenol A results in decreased expression of DOPEY2 mRNA | CTD | PMID:30816183 and PMID:32145629 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of DOP1B gene | CTD | PMID:28505145 | caffeine | affects phosphorylation | ISO | DOP1B (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of DOP1B protein | CTD | PMID:35688186 | carbon nanotube | decreases expression | ISO | Dop1b (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | carbon nanotube | increases expression | ISO | Dop1b (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of DOP1B mRNA | CTD | PMID:25620056 | CGP 52608 | multiple interactions | ISO | DOP1B (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to DOPEY2 gene] | CTD | PMID:28238834 | chromium(6+) | affects expression | ISO | Dop1b (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of DOP1B mRNA | CTD | PMID:28472532 | cisplatin | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of DOP1B mRNA | CTD | PMID:27392435 and PMID:27594783 | copper(II) sulfate | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of DOP1B mRNA | CTD | PMID:19549813 | coumestrol | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of DOP1B mRNA | CTD | PMID:19167446 | crocidolite asbestos | decreases expression | ISO | Dop1b (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of DOP1B mRNA | CTD | PMID:29279043 | cyclosporin A | increases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of DOP1B mRNA | CTD | PMID:25562108 | decabromodiphenyl ether | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of DOP1B protein | CTD | PMID:31675489 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of DOP1B mRNA | CTD | PMID:21266533 | dioxygen | affects methylation | ISO | Dop1b (Mus musculus) | 6480464 | Oxygen deficiency affects the methylation of DOP1B promoter | CTD | PMID:24205000 | dioxygen | multiple interactions | ISO | Dop1b (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DOP1B mRNA | CTD | PMID:30529165 | dioxygen | increases expression | ISO | Dop1b (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of DOP1B mRNA | CTD | PMID:24205000 | epoxiconazole | decreases expression | ISO | Dop1b (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of DOP1B mRNA | CTD | PMID:35436446 | ethanol | increases expression | ISO | Dop1b (Mus musculus) | 6480464 | Ethanol results in increased expression of DOP1B mRNA | CTD | PMID:19167417 | FR900359 | decreases phosphorylation | ISO | DOP1B (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of DOP1B protein | CTD | PMID:37730182 | hydrogen peroxide | affects expression | ISO | DOP1B (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of DOP1B mRNA | CTD | PMID:21179406 | isotretinoin | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of DOP1B mRNA | CTD | PMID:20436886 | methapyrilene | decreases methylation | ISO | DOP1B (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of DOP1B intron | CTD | PMID:30157460 | methyl methanesulfonate | increases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of DOP1B mRNA | CTD | PMID:23649840 | ozone | multiple interactions | ISO | Dop1b (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of DOPEY2 mRNA | CTD | PMID:27106289 | paracetamol | increases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of DOP1B mRNA | CTD | PMID:22230336 and PMID:29067470 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Dop1b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DOPEY2 mRNA | CTD | PMID:36331819 | pirinixic acid | increases expression | ISO | Dop1b (Mus musculus) | 6480464 | pirinixic acid results in increased expression of DOP1B mRNA | CTD | PMID:18301758 | pirinixic acid | multiple interactions | ISO | Dop1b (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DOP1B mRNA | CTD | PMID:19710929 | potassium chromate | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of DOP1B mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | DOP1B (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DOP1B mRNA | CTD | PMID:22079256 | potassium dichromate | decreases expression | ISO | Dop1b (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of DOP1B mRNA | CTD | PMID:23608068 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Dop1b (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of DOP1B mRNA | CTD | PMID:28903501 | propiconazole | increases expression | ISO | Dop1b (Mus musculus) | 6480464 | propiconazole results in increased expression of DOP1B mRNA | CTD | PMID:21278054 | rac-lactic acid | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of DOPEY2 mRNA | CTD | PMID:30851411 | sodium arsenite | increases expression | ISO | Dop1b (Mus musculus) | 6480464 | sodium arsenite results in increased expression of DOP1B mRNA | CTD | PMID:36209798 | temozolomide | decreases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of DOP1B mRNA | CTD | PMID:31758290 | tris(2-butoxyethyl) phosphate | affects expression | ISO | DOP1B (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of DOP1B mRNA | CTD | PMID:29024780 | urethane | increases expression | ISO | DOP1B (Homo sapiens) | 6480464 | Urethane results in increased expression of DOP1B mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | DOP1B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of DOP1B mRNA | CTD | PMID:25979313 | valproic acid | affects expression | ISO | Dop1b (Mus musculus) | 6480464 | Valproic Acid affects the expression of DOP1B mRNA | CTD | PMID:17963808 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of DOP1B mRNA | CTD | PMID:23034163 | |